A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05
Authors
Keywords
-
Journal
OSTEOPOROSIS INTERNATIONAL
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2021-05-18
DOI
10.1007/s00198-021-05996-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Design of a randomized trial of teriparatide followed by alendronate: Japanese Osteoporosis Intervention Trial-05 (JOINT-05)
- (2020) Shiro Tanaka et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Pharmacological Management of Osteoporosis in Postmenopausal Women: An Endocrine Society* Clinical Practice Guideline
- (2019) Richard Eastell et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Clinical effectiveness of denosumab, raloxifene, romosozumab, and teriparatide for the prevention of osteoporotic fragility fractures: A systematic review and network meta-analysis
- (2019) E.L. Simpson et al. BONE
- Effects of teriparatide and risedronate on new fractures in post-menopausal women with severe osteoporosis (VERO): a multicentre, double-blind, double-dummy, randomised controlled trial
- (2018) David L Kendler et al. LANCET
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2018) J.A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Administration frequency as well as dosage of PTH are associated with development of cortical porosity in ovariectomized rats
- (2017) Aya Takakura et al. Bone Research
- Acute development of cortical porosity and endosteal naïve bone formation from the daily but not weekly short-term administration of PTH in rabbit
- (2017) Hiroshi Yamane et al. PLoS One
- Frequency of Teriparatide Administration Affects the Histological Pattern of Bone Formation in Young Adult Male Mice
- (2016) Tomomaya Yamamoto et al. ENDOCRINOLOGY
- Diagnostic criteria for primary osteoporosis: year 2012 revision
- (2013) Satoshi Soen et al. JOURNAL OF BONE AND MINERAL METABOLISM
- Vertebral fracture risk after once-weekly teriparatide injections: follow-up study of Teriparatide Once-Weekly Efficacy Research (TOWER) trial
- (2012) Toshitsugu Sugimoto et al. CURRENT MEDICAL RESEARCH AND OPINION
- Randomized Teriparatide [Human Parathyroid Hormone (PTH) 1–34] Once-Weekly Efficacy Research (TOWER) Trial for Examining the Reduction in New Vertebral Fractures in Subjects with Primary Osteoporosis and High Fracture Risk
- (2012) Toshitaka Nakamura et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comparative Effectiveness of Drug Treatments to Prevent Fragility Fractures: A Systematic Review and Network Meta-Analysis
- (2012) Mohammad Hassan Murad et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Effects of a single injection of teriparatide on bone turnover markers in postmenopausal women
- (2012) M. Shiraki et al. OSTEOPOROSIS INTERNATIONAL
- Vertebral fracture assessment using a semiquantitative technique
- (2010) Harry K. Genant et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Sequential Treatment of Severe Postmenopausal Osteoporosis After Teriparatide: Final Results of the Randomized, Controlled European Study of Forsteo (EUROFORS)*
- (2008) Richard Eastell et al. JOURNAL OF BONE AND MINERAL RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now